Recently, Maxunitech bought out some of the original shareholders of Inner Mongolia Shijie Chemical with their own funds to control the company.
Shijie, established in 2018 and located in the High Link Economic and Technological Development Zone in Inner Mongolia, is a manufacturing enterprise integrating the research, development, production, and sales of pesticides and fine chemicals.
Shijie also has production lines for sulpentrazone, flumioxazin and several chemical intermediates, as well as a land bank for several new projects.
Maxunitech lnc, founded in 2000, is an international company engaged in plant protection, aquatic ecological restoration and reconstruction, and environmental engineering.
Maxunitech LLC already has sulpentrazone and flumioxacin production capacity. However, after acquiring the shares of Shijie Chemical, Maxunitech lnc became the world leader with a total annual production of 1000 tonnes of sulpentrazone and 3 000 tonnes of flumioxazin.
Maxunitech CEO Dr. Huang said the company has completed product registration and market placement in North America, South America, Australia, China and other key agrochemical markets around soybeans, sugarcane, cotton, wheat and other crops. customers and farmers in agricultural markets in North America and China, creating a product portfolio for specific markets and crops to meet the needs of customers and farmers.
After taking control of Shijie Chemical, Maxunitech now has three production bases for technical substances and one for formulations, which means that the arrangement of production is more reasonable.
The new production capacity of Sulfentrazone and Flumioxazin, including the full integration of key intermediates into the supply chain, has effectively improved the company’s product supply capacity, supply stability, and cost competitiveness. All this increased the influence of Maxunitech in the world market. In the future, Maxunitech will continue to make great efforts in R&D, registration, production, and supply as soon as possible to promote the production and projects of pinoxaden, protoconazole, saflufenacil, and other products with independent intellectual property rights to provide more and better products. and services to new and old customers around the world.